FI20095638A0 - Hydrofobiineja aktiivisten aineiden dispergointiin - Google Patents

Hydrofobiineja aktiivisten aineiden dispergointiin

Info

Publication number
FI20095638A0
FI20095638A0 FI20095638A FI20095638A FI20095638A0 FI 20095638 A0 FI20095638 A0 FI 20095638A0 FI 20095638 A FI20095638 A FI 20095638A FI 20095638 A FI20095638 A FI 20095638A FI 20095638 A0 FI20095638 A0 FI 20095638A0
Authority
FI
Finland
Prior art keywords
hydrophobins
active substances
dispersing active
dispersing
substances
Prior art date
Application number
FI20095638A
Other languages
English (en)
Swedish (sv)
Inventor
Paeivi Laaksonen
Markus Linder
Timo Laaksonen
Hanna Valo
Jouni Hirvonen
Original Assignee
Valtion Teknillinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen filed Critical Valtion Teknillinen
Priority to FI20095638A priority Critical patent/FI20095638A0/fi
Publication of FI20095638A0 publication Critical patent/FI20095638A0/fi
Priority to PCT/FI2010/050475 priority patent/WO2010142850A1/en
Priority to CN2010800259730A priority patent/CN102802669A/zh
Priority to US13/377,188 priority patent/US20120135081A1/en
Priority to RU2011152810/15A priority patent/RU2011152810A/ru
Priority to EP10785798A priority patent/EP2440248A4/en
Priority to BRPI1013079A priority patent/BRPI1013079A2/pt
Priority to CA2764828A priority patent/CA2764828A1/en
Priority to JP2012514502A priority patent/JP2012529479A/ja
Priority to AU2010258531A priority patent/AU2010258531A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/10Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5169Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D189/00Coating compositions based on proteins; Coating compositions based on derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
FI20095638A 2009-06-09 2009-06-09 Hydrofobiineja aktiivisten aineiden dispergointiin FI20095638A0 (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20095638A FI20095638A0 (fi) 2009-06-09 2009-06-09 Hydrofobiineja aktiivisten aineiden dispergointiin
PCT/FI2010/050475 WO2010142850A1 (en) 2009-06-09 2010-06-09 Hydrophobins for dispersing active agents
CN2010800259730A CN102802669A (zh) 2009-06-09 2010-06-09 用于分散活性剂的疏水蛋白
US13/377,188 US20120135081A1 (en) 2009-06-09 2010-06-09 Hydrophobins for dispersing active agents
RU2011152810/15A RU2011152810A (ru) 2009-06-09 2010-06-09 Гидрофобины для диспергирования активных агентов
EP10785798A EP2440248A4 (en) 2009-06-09 2010-06-09 HYDROPHOBINE FOR ACTIVE DISPERSIONS
BRPI1013079A BRPI1013079A2 (pt) 2009-06-09 2010-06-09 hidrofobinas para dispersao de agentes ativos
CA2764828A CA2764828A1 (en) 2009-06-09 2010-06-09 Hydrophobins for dispersing active agents
JP2012514502A JP2012529479A (ja) 2009-06-09 2010-06-09 活性作用物質を分散させるためのハイドロフォビン
AU2010258531A AU2010258531A1 (en) 2009-06-09 2010-06-09 Hydrophobins for dispersing active agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20095638A FI20095638A0 (fi) 2009-06-09 2009-06-09 Hydrofobiineja aktiivisten aineiden dispergointiin

Publications (1)

Publication Number Publication Date
FI20095638A0 true FI20095638A0 (fi) 2009-06-09

Family

ID=40825343

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20095638A FI20095638A0 (fi) 2009-06-09 2009-06-09 Hydrofobiineja aktiivisten aineiden dispergointiin

Country Status (10)

Country Link
US (1) US20120135081A1 (fi)
EP (1) EP2440248A4 (fi)
JP (1) JP2012529479A (fi)
CN (1) CN102802669A (fi)
AU (1) AU2010258531A1 (fi)
BR (1) BRPI1013079A2 (fi)
CA (1) CA2764828A1 (fi)
FI (1) FI20095638A0 (fi)
RU (1) RU2011152810A (fi)
WO (1) WO2010142850A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2750421C (en) * 2008-11-27 2016-10-18 B.R.A.I.N. Biotechnology Research And Information Network Ag Surface active proteins as excipients in solid pharmaceutical formulations
FI130619B (fi) 2011-11-15 2023-12-15 Upm Kymmene Corp Matriisi bioaktiivisten aineiden hallittuun vapauttamiseen
CA2878276A1 (en) * 2012-07-10 2014-01-16 Cellutech Ab Nfc stabilized foam
EP3335696B1 (en) * 2016-12-15 2019-12-18 UPM-Kymmene Corporation A method for drying cell-free tissue extract in a hydrogel comprising nanofibrillar cellulose and a dried hydrogel comprising nanofibrillar cellulose and cell-free tissue extract
EP3335695B1 (en) 2016-12-15 2020-02-05 UPM-Kymmene Corporation A method for freeze-drying hydrogel comprising nanofibrillar cellulose, a freeze-dried medical hydrogel comprising nanofibrillar cellulose, and a hydrogel comprising nanofibrillar cellulose
WO2020087083A1 (en) * 2018-10-26 2020-04-30 Shoreditch-Son Co., Ltd. COMPACT-PODS OF NUTRIENTS THAT DlSSOLVE IN LIQUID SOLUTIONS AND MANUFACTURING METHODS THEREOF
EP3791864A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Method for preparing pharmaceutical composition and pharmaceutical composition
EP3791858A1 (en) * 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137684B2 (en) * 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
GB0007770D0 (en) * 2000-03-30 2000-05-17 Biomade B V Protein capable of self-assembly at a hydrophobic hydrophillic interface, method of coating a surface, method of stabilizing a dispersion, method of stabilizi
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
WO2005068087A2 (en) * 2004-01-16 2005-07-28 Applied Nanosystems B.V. Method for coating an object with hydrophobin at low temperatures
WO2006010425A1 (en) * 2004-07-27 2006-02-02 Unilever Plc Aerated food products containing hydrophobin
US7241734B2 (en) * 2004-08-18 2007-07-10 E. I. Du Pont De Nemours And Company Thermophilic hydrophobin proteins and applications for surface modification
DE102005027039A1 (de) * 2005-06-10 2006-12-21 Basf Ag Hydrophobin als Beschichtungsmittel für expandierbare oder expandierte, thermoplastische Polymerpartikel
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
EP2033619A1 (de) * 2007-08-24 2009-03-11 Basf Se Verfahren zum Dispergieren von ionischen Nanopartikeln
BRPI0816256A2 (pt) * 2007-09-13 2015-03-17 Basf Se Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico
JP2011527668A (ja) * 2008-07-11 2011-11-04 ビーエーエスエフ ソシエタス・ヨーロピア 形態改質剤としての両親媒性タンパク質
CA2750421C (en) * 2008-11-27 2016-10-18 B.R.A.I.N. Biotechnology Research And Information Network Ag Surface active proteins as excipients in solid pharmaceutical formulations

Also Published As

Publication number Publication date
WO2010142850A1 (en) 2010-12-16
EP2440248A1 (en) 2012-04-18
BRPI1013079A2 (pt) 2017-06-06
AU2010258531A1 (en) 2011-12-15
EP2440248A4 (en) 2013-02-13
RU2011152810A (ru) 2013-07-20
CA2764828A1 (en) 2010-12-16
US20120135081A1 (en) 2012-05-31
JP2012529479A (ja) 2012-11-22
CN102802669A (zh) 2012-11-28

Similar Documents

Publication Publication Date Title
BRPI1012247A2 (pt) compostos inseticidas
BRPI1015931A2 (pt) Compostos inseticidas
DK2225988T3 (da) Dispenserhus
BR112012006859A2 (pt) compostos
DK2427449T3 (da) Vinylindazolylforbindelser
DK2648799T3 (da) Elektrodeanordning
DK3320979T3 (da) Dispenser
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
BRPI1013941A2 (pt) compostos inseticidas
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
FI20095638A0 (fi) Hydrofobiineja aktiivisten aineiden dispergointiin
BRPI1014641A2 (pt) arilpirrolidinas pesticidas
BRPI1012729A2 (pt) dispensador
FR2948037B1 (fr) Materiau photocatalytique
BRPI1006968A2 (pt) microbiocidas
BRPI1010159A2 (pt) bistuti
IT1397007B1 (it) Dispenser
ITPD20090053U1 (it) Paradordi per banchine
ES1070429Y (es) Traspaleta mejorada
BRPI0924738A2 (pt) Herbicidas
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas

Legal Events

Date Code Title Description
FD Application lapsed